(Q44931209)

7 December 2017

Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice (English)

1 reference

7 December 2017

0 references

13

Neal G Copeland

1 reference

7 December 2017

12

Nancy A Jenkins

1 reference

7 December 2017

14

Christopher A Ross

1 reference

7 December 2017

Gabriele Schilling

1

1 reference

7 December 2017

Alena V Savonenko

2

1 reference

7 December 2017

Alexandra Klevytska

3

1 reference

7 December 2017

Johanna L Morton

4

1 reference

7 December 2017

Stina M Tucker

5

1 reference

7 December 2017

Michelle Poirier

6

1 reference

7 December 2017

Alexa Gale

7

1 reference

7 December 2017

Ning Chan

8

1 reference

7 December 2017

Vicky Gonzales

9

1 reference

7 December 2017

Hilda H Slunt

10

1 reference

7 December 2017

Michael L Coonfield

11

1 reference

7 December 2017

David R Borchelt

15

1 reference

7 December 2017

9 June 2004

1 reference

7 December 2017

Human Molecular Genetics

1 reference

7 December 2017

13

1 reference

7 December 2017

1599-1610

1 reference

7 December 2017

15

1 reference

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

7 December 2017

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Trinucleotide repeats in neurogenetic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

When more is less: pathogenesis of glutamine repeat neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Huntington's disease and dentatorubral-pallidoluysian atrophy: proteins, pathogenesis and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Neurological abnormalities in a knock-in mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Nuclear targeting of mutant Huntingtin increases toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Decreased expression of striatal signaling genes in a mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Disruption of Axonal Transport by Loss of Huntingtin or Expression of Pathogenic PolyQ Proteins in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Polyglutamine pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

A vector for expressing foreign genes in the brains and hearts of transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Distinct behavioral and neuropathological abnormalities in transgenic mouse models of HD and DRPLA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Nucleocytoplasmic transport signals affect the age at onset of abnormalities in knock-in mice expressing polyglutamine within an ectopic protein context

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Widespread expression of Huntington's disease gene (IT15) protein product

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Huntingtin contains a highly conserved nuclear export signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Atrophin-1, the DRPLA gene product, interacts with two families of WW domain-containing proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Drosophila atrophin homolog functions as a transcriptional corepressor in multiple developmental processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Aberrant histone acetylation, altered transcription, and retinal degeneration in a Drosophila model of polyglutamine disease are rescued by CREB-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Decreased cAMP response element-mediated transcription: an early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Ultrastructure of nuclear aggregates formed by expressing an expanded polyglutamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Interaction of expanded polyglutamine stretches with nuclear transcription factors leads to aberrant transcriptional regulation in polyglutamine diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Interaction of Huntington disease protein with transcriptional activator Sp1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Inhibition of tryptophan hydroxylase activity and decreased 5-HT1A receptor binding in a mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

The predominantly HEAT-like motif structure of huntingtin and its association and coincident nuclear entry with dorsal, an NF-kB/Rel/dorsal family transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

CRE-mediated transcription is increased in Huntington's disease transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

Huntington's disease: a synaptopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

A huntingtin-associated protein enriched in brain with implications for pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

HIP-I: a huntingtin interacting protein isolated by the yeast two-hybrid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

The huntingtin interacting protein HIP1 is a clathrin and alpha-adaptin-binding protein involved in receptor-mediated endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDH175

21 January 2018

Identifiers

DOI

10.1093/HMG/DDH175

1 reference

7 December 2017

1 reference